Patent · US Active

Method of treating coccidioides infection

US11819503B2 · kind B2 · utility

0Cited by
26References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 22, 2020
Grant dateNov 21, 2023
Priority date
Expiry dateMay 1, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the therapeutic use of olorofim, 2-(1,5-dimethyl-3-phenyl-1H-pyrrol-2-yl)-N-(4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-2-oxoacetamide in the prevention and treatment of a fungal infection caused by a Coccidioides species.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.